Literature DB >> 26424260

Prediction of Antibody Epitopes.

Morten Nielsen1,2, Paolo Marcatili3.   

Abstract

Antibodies recognize their cognate antigens in a precise and effective way. In order to do so, they target regions of the antigenic molecules that have specific features such as large exposed areas, presence of charged or polar atoms, specific secondary structure elements, and lack of similarity to self-proteins. Given the sequence or the structure of a protein of interest, several methods exploit such features to predict the residues that are more likely to be recognized by an immunoglobulin. Here, we present two methods (BepiPred and DiscoTope) to predict linear and discontinuous antibody epitopes from the sequence and/or the three-dimensional structure of a target protein.

Keywords:  Discontinuous epitope; Epitope; Linear epitope; Prediction

Mesh:

Substances:

Year:  2015        PMID: 26424260     DOI: 10.1007/978-1-4939-2999-3_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  FtlA and FtlB Are Candidates for Inclusion in a Next-Generation Multiantigen Subunit Vaccine for Lyme Disease.

Authors:  Andrew C Camire; Nathaniel S O'Bier; Dhara T Patel; Nicholas A Cramer; Reinhard K Straubinger; Edward B Breitschwerdt; Rebecca A Funk; Richard T Marconi
Journal:  Infect Immun       Date:  2022-09-14       Impact factor: 3.609

2.  Conserved HIV Epitopes for an Effective HIV Vaccine.

Authors:  Bikash Sahay; Cuong Q Nguyen; Janet K Yamamoto
Journal:  J Clin Cell Immunol       Date:  2017-08-30

3.  Proteome-wide mapping of immune features onto Plasmodium protein three-dimensional structures.

Authors:  Andrew J Guy; Vashti Irani; James G Beeson; Benjamin Webb; Andrej Sali; Jack S Richards; Paul A Ramsland
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

4.  Benchmarking the PEPOP methods for mimicking discontinuous epitopes.

Authors:  Vincent Demolombe; Alexandre G de Brevern; Franck Molina; Géraldine Lavigne; Claude Granier; Violaine Moreau
Journal:  BMC Bioinformatics       Date:  2019-12-30       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.